Ferring SA
13.8 FTEThe score of Ferring shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -8 % Equity -32 % Total assets 0 % Headcount (avg FTE) -25 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ferring's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 13 Oct 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Ferring's financial analysis
- Solvency28.1%sector median: 41.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ferring
Ferring's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0428.038.135
- VAT number
- BE0428038135
- Peppol
- Registered · 0208:0428038135 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 12 Feb 1985
- Registered office
- 1070 Anderlecht
- Size
- Small · 13.8 FTE
- Latest accounts
- 2025 · filed on 13 Oct 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Ferring (SA) has been based in Anderlecht since 1985, active in: manufacture of medicaments. For 2025, it reports revenue of €20.4m, a net profit of 457,511 € and equity of €3.09m. With 13.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 28.1%, below the median of its sector (41.4%).
Companies similar to Ferring
Companies in the same business, of comparable size and area, outside its group.
- Axone Pharma Activities of agents involved in the wholesale of other particular products Braine-l'Alleud · balance sheet €16.2m
- Cochlear Benelux Activities of agents involved in the wholesale of other particular products Mechelen · balance sheet €9.69m
- Creo Medical Activities of agents involved in the wholesale of other particular products Anderlecht · balance sheet €4.31m
- Bio-Fields Activities of agents involved in the wholesale of other particular products Anzegem · balance sheet €10.8m
- Alexion Pharma Belgium Manufacture of pharmaceutical preparations Brussels · balance sheet €8.68m
- Immo Roelandt Activities of agents involved in the wholesale of other particular products Halle · balance sheet €12.6m
- Geotech Activities of agents involved in the wholesale of other particular products Hensies · balance sheet €9.45m
- Sanomed Activities of agents involved in the wholesale of other particular products Rotselaar · balance sheet €2.58m
Frequently asked questions about Ferring
What is the revenue of Ferring?
According to the 2025 annual accounts filed with the NBB, the revenue of Ferring amounts to 20,376,544 €.
What is the VAT number of Ferring?
In Belgium, the VAT number is the company number prefixed with BE: BE0428038135 for Ferring, if the company is VAT-registered. Its company number (CBE) is 0428.038.135.
Where is the registered office of Ferring?
According to the CBE register, the registered office of Ferring is in 1070 Anderlecht.
What is the equity of Ferring?
At the close of the 2025 financial year, the equity of Ferring amounts to 3,087,509 €, a solvency of 28.1% of total assets.
How many people work at Ferring?
13.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ferring?
The register lists 3 active mandates at Ferring. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ferring
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →